MYCN and cancer: In the past decade, the multitude of genome-wide sequencing studies of primary tumors, enabled by technological advances in next-generation sequencing and data analysis [25], further established MYC as one of the most frequently amplified genes across human cancers and revealed new cancer types that harbor MYC, MYCN, and MYCL amplifications (Summarized in Figure 1a).